K-Bio fever continues to be strong this year. From early this year, domestic pharmaceutical and
biopharma companies have successfully developed new drugs and exported related technologies.
They develop new drugs through open-innovation and export not only novel medicines and but also
the platform technologies, raising the status of Korean bioproducts in the world.
Against this backdrop, pharmaceutical and biopharma companies will mobilize 10 trillion won by 2023 to promote
bio and health sectors, which are considered the next-generation core industries. The government, by expanding
the bio-and-health-related R&D budget by 30%, actively supporting the boom in the bio industry.
One area that is garnering attention in the pharmaceutical industry is the platform technologies, which have
the potential to be the foundation of new drug development. The next-generation drug development platforms
not only raise the possibility of successful identification of drug candidates but are becoming the original technology
that increases the diversity and efficiency in developing new molecules.
Thus, the R&D investment on new drug development is escalating across the globe, and platform technologies
are rising as a new growth engine for pharma and biopharma companies. It was also applied in developing
the COVID-19 vaccine recently.
Utilizing technologies like artificial intelligence, big data, organoid and 3D-printing, the platform technology
is the core driver in improving efficiency in drug development process. Thus, the application of this technology
can reduce time and cost in novel drug research and development, and it can enable the development of
other new drugs from one molecule and open the opportunity for pharmaceutical firms to out-license drugs.
As such, the Financial News is hosting the 13th Seoul International New Pharmaceuticals Forum as a venue
to discuss new opportunities platform technologies provide in drug development with the experts and representatives
from related organizations.
Title : The 13th Seoul International New Pharmaceuticals Forum
Theme : Transition in the New Drug Development Platforms
Date : June 17th, 2021(Thu) 09:00~12:00
Venue : Orchid, The Westin Josun Seoul Hotel
Hosts : The Financial News,
Korea Research Institute of Chemical Technology
Sponsors : Ministry of Health and Welfare, Ministry of Science and ICT,
Ministry of Trade, Industry and Energy,
Ministry of Food and Drug Safety,
Korea Pharmaceutical and Bio-Pharma Manufacturers Association,
Korea Biotechnology Industry Organization,
Korea Research-based Pharma Industry Association
Contact : Seoul International New Pharmaceuticals Forum Bureau